India Patents
-
{
- All
- News
-
India Has 127 Global Patents For 6G Technology: Minister Ashwini Vaishnaw
- Wednesday March 22, 2023
- India News | Press Trust of India
India now has over 127 global patents for 6G technology, Union Minister for Communications Ashwini Vaishnaw said on Wednesday.
-
www.ndtv.com
-
Delhi HC Delivers Deadly Blow To Agro-Biotech In Monsanto-Nuziveedu Ruling
- Thursday April 26, 2018
- Author: Prashant Reddy, SpicyIP
Monsanto’s decision to waive right to trial on patent validity was either incredibly brave or over-confident.
-
www.ndtvprofit.com
-
Government Defends Right To Issue Drug "Compulsory Licences"
- Wednesday March 23, 2016
- Thomson Reuters
India has defended its right to grant licences allowing local firms to override patents and make cheaper copies of drugs discovered by big Western drugmakers, and said reports to the contrary were "factually incorrect".
-
www.ndtvprofit.com
-
BDR seeks compulsory licence for cancer drug; offers 95 per cent cheaper generic copy
- Wednesday March 27, 2013
Drug firm BDR Pharmaceuticals has applied for a compulsory licence to market generic version of US-based Bristol-Myers Squibb's cancer drug Dasatinib, sold under 'Sprycel' brand, promising to offer the product at price cheaper by over 95 per cent for a month's treatment.
-
www.ndtvprofit.com
-
India Has 127 Global Patents For 6G Technology: Minister Ashwini Vaishnaw
- Wednesday March 22, 2023
- India News | Press Trust of India
India now has over 127 global patents for 6G technology, Union Minister for Communications Ashwini Vaishnaw said on Wednesday.
-
www.ndtv.com
-
Delhi HC Delivers Deadly Blow To Agro-Biotech In Monsanto-Nuziveedu Ruling
- Thursday April 26, 2018
- Author: Prashant Reddy, SpicyIP
Monsanto’s decision to waive right to trial on patent validity was either incredibly brave or over-confident.
-
www.ndtvprofit.com
-
Government Defends Right To Issue Drug "Compulsory Licences"
- Wednesday March 23, 2016
- Thomson Reuters
India has defended its right to grant licences allowing local firms to override patents and make cheaper copies of drugs discovered by big Western drugmakers, and said reports to the contrary were "factually incorrect".
-
www.ndtvprofit.com
-
BDR seeks compulsory licence for cancer drug; offers 95 per cent cheaper generic copy
- Wednesday March 27, 2013
Drug firm BDR Pharmaceuticals has applied for a compulsory licence to market generic version of US-based Bristol-Myers Squibb's cancer drug Dasatinib, sold under 'Sprycel' brand, promising to offer the product at price cheaper by over 95 per cent for a month's treatment.
-
www.ndtvprofit.com